CaringKind, New York’s leading organization in caring for Alzheimer’s disease and dementia patients for the past 30 years, has…
Articles by Ana de Barros, PhD
Muses Labs and Metabolon announced they have entered into a partnership to assess the application of metabolomics in people…
NeuroVision Imaging has raised $10 million in new funding through a Series B financing round, led by a $5…
New York City-based Intra-Cellular Therapies has started its ITI-007-201 Phase 3 clinical trial for the treatment of agitation in patients…
In an effort to promote education about Alzheimer’s disease and help local communities plan for this emerging public health crisis,…
Muses Labs has partnered with the George Washington Center for Integrative Medicine (GWCIM) to offer Alzheimer’s disease…
The U.S. Senate Appropriations Committee  has forwarded a draft bill that could deliver nearly $1.4 billion in federal funds to Alzheimer’s…
Swedish researchers demonstrated that a heart medication can reduce the build-up of plaque in brain blood vessels in mice. If findings…
The Alzheimer’s Association will use Alzheimer’s & Brain Awareness Month to debunk myths related to  the disease, while raising awareness…
A new study led by biomedical scientists at Indiana University has revealed evidence that the NMNAT2 enzyme may be protective…